US FDA News: FDA approves new treatment for a rare genetic disorder, Fabry disease

FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
Read more: FDA approves new treatment for a rare genetic disorder, Fabry disease